share_log

艾美疫苗:董事會會議通告

AIM VACCINE: NOTICE OF BOARD MEETING

HKEX ·  Aug 19 04:57

Summary by Moomoo AI

艾美疫苗股份有限公司宣布,將於2024年8月29日(星期四)召開董事會會議,屆時將考慮及批准截至2024年6月30日止六個月的中期業績及其發佈。會議同時將討論是否建議派發中期股息及處理其他事宜。該會議將由董事會主席、執行董事兼首席執行官周延先生主持,並於2024年8月19日由周延先生發出通告。本公司董事會成員包括執行董事關文先生、賈紹君先生,非執行董事周杰先生、周欣先生、趙繼臣先生及王愛軍女士,以及獨立非執行董事。
艾美疫苗股份有限公司宣布,將於2024年8月29日(星期四)召開董事會會議,屆時將考慮及批准截至2024年6月30日止六個月的中期業績及其發佈。會議同時將討論是否建議派發中期股息及處理其他事宜。該會議將由董事會主席、執行董事兼首席執行官周延先生主持,並於2024年8月19日由周延先生發出通告。本公司董事會成員包括執行董事關文先生、賈紹君先生,非執行董事周杰先生、周欣先生、趙繼臣先生及王愛軍女士,以及獨立非執行董事。
Aimei Vaccine Co., Ltd. announced that it will hold a board of directors meeting on Thursday, August 29, 2024, to consider and approve the mid-term performance up to June 30, 2024, and its release. The meeting will also discuss whether to recommend the distribution of mid-term dividends and handle other matters. The meeting will be chaired by the Chairman of the Board, Executive Director and CEO Mr. Zhou Yan and announced by Mr. Zhou Yan on August 19, 2024. The company's board of directors consists of Executive Director Mr. Guan Wen, Mr. Jia Shaojun, Non-executive Director Mr. Zhou Jie, Mr. Zhou Xin, Mr. Zhao Jichen and Ms. Wang Aijun, as well as independent non-executive directors.
Aimei Vaccine Co., Ltd. announced that it will hold a board of directors meeting on Thursday, August 29, 2024, to consider and approve the mid-term performance up to June 30, 2024, and its release. The meeting will also discuss whether to recommend the distribution of mid-term dividends and handle other matters. The meeting will be chaired by the Chairman of the Board, Executive Director and CEO Mr. Zhou Yan and announced by Mr. Zhou Yan on August 19, 2024. The company's board of directors consists of Executive Director Mr. Guan Wen, Mr. Jia Shaojun, Non-executive Director Mr. Zhou Jie, Mr. Zhou Xin, Mr. Zhao Jichen and Ms. Wang Aijun, as well as independent non-executive directors.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more